Back
Vertex Pharmaceuticals Incorpor (VRTX)
BiotechnologyVRTX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$522.25
−1.39%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$15.32
ROE
24.2%
Gross margin
54.4%
Debt/Equity
0.10x
Revenue growth
7.8%
Vertex Pharmaceuticals Incorpor — company intelligence
Earnings surprises
Q1 2026$4.47 vs $4.40 est+1.7%
Q4 2025$5.03 vs $5.17 est-2.8%
Q3 2025$4.80 vs $4.65 est+3.1%
Q2 2025$4.52 vs $4.37 est+3.4%
Insider activity · 90 days
19 buys9 sellsnet +6,709 shares
Bozic CarmenSell 1,020 · Jun 18, 2026
Bozic CarmenSell 1,745 · Jun 5, 2026
Liu JoySell 828 · Jun 1, 2026
Recent SEC filings
4 — Insider transaction reportJul 7, 2026
4 — Insider transaction reportJul 7, 2026
8-K — Material event reportJul 7, 2026
Latest news
Is This Biotech Stock a Buy Near Its 52-Week High? — Yahoo · 14h ago
Why This Pharmaceutical Stock Jumped Close to 100% This Week — Yahoo · 16h ago
If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago, This is How Much It'd Be Worth Now — Yahoo · 23h ago
The Long Climb Back For Ionis Stock — Yahoo · 1d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Vertex Pharmaceuticals Incorpor
Weekly undervalued picks (like VRTX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.